Background To better understand a potential association of elevated C-reactive protein
(CRP) level with progression of chronic kidney disease (CKD), we examined the relationship
of CRP level with the development of end-stage renal disease (ESRD) in the Trial to Reduce
Cardiovascular Events With Aranesp Therapy (TREAT). Study Design Post hoc analysis of a
randomized controlled trial. Setting & Participants 4,038 patients with type 2 diabetes, CKD,
and anemia in TREAT. Predictor Baseline serum CRP concentrations. Outcomes The …

Background: To better understand a potential association of elevated C-reactive protein
(CRP) level with progression of chronic kidney disease (CKD), we examined the relationship
of CRP level with the development of end-stage renal disease (ESRD) in the Trial to Reduce
Cardiovascular Events With Aranesp Therapy (TREAT). Study Design: Post hoc analysis of a
randomized controlled trial. Setting & Participants: 4,038 patients with type 2 diabetes, CKD,
and anemia in TREAT. Predictor: Baseline serum CRP concentrations. Outcomes: The …